Seres Therapeutics Company Profile (NASDAQ:MCRB)

About Seres Therapeutics

Seres Therapeutics logoSeres Therapeutics, Inc. is a microbiome therapeutics platform company. The Company is engaged in developing a class of biological drugs, which is referred as Ecobiotic microbiome therapeutics. The Company is focused on implementing its microbiome therapeutics platform to develop Ecobiotic microbiome therapeutics that treats dysbiosis in the colonic microbiome. SER-109 is its lead product candidate, which is designed to prevent further recurrences of Clostridium difficile infection (CDI). The Company is developing additional product candidates, including SER-262 to prevent an initial recurrence of primary CDI, SER-287 to treat inflammatory bowel disease (IBD), including ulcerative colitis, and SER-155 to treat enteric bacterial pathogens. The Company is also conducting research on metabolic diseases, such as early-stage, non-insulin dependent diabetes; obesity and metabolic syndrome; other inflammatory diseases; cancer chemotherapy and immune suppression, and rare genetic diseases.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: MCRB
  • CUSIP:
Key Metrics:
  • Previous Close: $13.02
  • 50 Day Moving Average: $11.23
  • 200 Day Moving Average: $24.02
  • 52-Week Range: $8.05 - $44.51
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -5.95
  • P/E Growth: -0.12
  • Market Cap: $524.37M
  • Outstanding Shares: 40,274,000
  • Beta: 0.28
Profitability:
  • Return on Equity: -41.73%
  • Return on Assets: -30.48%
Debt:
  • Debt-to-Equity Ratio: 0.05%
  • Current Ratio: 7.94%
  • Quick Ratio: 7.94%
Additional Links:
Companies Related to Seres Therapeutics:

Analyst Ratings

Consensus Ratings for Seres Therapeutics (NASDAQ:MCRB) (?)
Ratings Breakdown: 1 Hold Rating, 6 Buy Ratings
Consensus Rating:Buy (Score: 2.86)
Consensus Price Target: $31.57 (142.48% upside)

Analysts' Ratings History for Seres Therapeutics (NASDAQ:MCRB)
Show:
DateFirmActionRatingPrice TargetDetails
8/12/2016FBR & CoLower Price TargetOutperform$43.00 -> $23.00View Rating Details
8/11/2016Leerink SwannReiterated RatingBuy$12.00View Rating Details
8/1/2016Canaccord GenuityReiterated RatingBuy$20.00View Rating Details
8/1/2016Bank of America Corp.DowngradeBuy -> NeutralView Rating Details
7/29/2016Cowen and CompanyReiterated RatingBuyView Rating Details
7/29/2016HC WainwrightInitiated CoverageBuy$50.00View Rating Details
3/3/2016GuggenheimInitiated CoverageBuy$41.00View Rating Details
2/22/2016Goldman Sachs Group Inc.Lower Price Target$35.00 -> $34.00View Rating Details
(Data available from 9/26/2014 forward)

Earnings

Earnings History for Seres Therapeutics (NASDAQ:MCRB)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/8/2016        
8/11/2016Q216($0.46)($0.70)$4.20 million$3.00 millionViewListenView Earnings Details
5/16/2016Q116($0.48)($0.50)$1.25 million$2.71 millionViewListenView Earnings Details
11/10/2015Q315($0.32)($0.38)ViewListenView Earnings Details
8/6/2015Q215($0.30)($1.45)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Seres Therapeutics (NASDAQ:MCRB)
Current Year EPS Consensus Estimate: $-2.33 EPS
Next Year EPS Consensus Estimate: $-2.19 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.54)($0.54)($0.54)
Q2 20162($0.62)($0.24)($0.43)
Q3 20162($0.49)($0.20)($0.35)
Q4 20162($0.58)($0.11)($0.35)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Seres Therapeutics (NASDAQ:MCRB)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Seres Therapeutics (NASDAQ:MCRB)
Insider Ownership Percentage: 41.90%
Institutional Ownership Percentage: 78.28%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/29/2016John G AuninsInsiderSell9,390$10.87$102,069.30View SEC Filing  
7/28/2016Michele TrucksisInsiderSell4,156$35.18$146,208.08View SEC Filing  
7/27/2016Michele TrucksisInsiderSell38,064$35.14$1,337,568.96View SEC Filing  
7/25/2016John G AuninsInsiderSell9,390$34.18$320,950.20View SEC Filing  
7/6/2016Roger PomerantzCEOSell88,211$29.45$2,597,813.95View SEC Filing  
7/1/2016Roger PomerantzCEOSell56,789$29.81$1,692,880.09View SEC Filing  
6/30/2016Eric D ShaffCFOSell4,533$29.54$133,904.82View SEC Filing  
6/28/2016Eric D ShaffCFOSell5,001$28.28$141,428.28View SEC Filing  
6/27/2016John G AuninsEVPSell9,390$27.23$255,689.70View SEC Filing  
6/2/2016David N CookEVPSell8,000$31.00$248,000.00View SEC Filing  
6/2/2016Roger PomerantzCEOSell74,049$32.52$2,408,073.48View SEC Filing  
6/1/2016David N CookEVPSell16,000$29.43$470,880.00View SEC Filing  
6/1/2016Roger PomerantzCEOSell70,951$30.51$2,164,715.01View SEC Filing  
5/25/2016Ventures Fund 2007 L FlagshipMajor ShareholderSell1,000,000$27.60$27,600,000.00View SEC Filing  
5/24/2016Roger PomerantzCEOSell9,801$30.00$294,030.00View SEC Filing  
5/6/2016Roger PomerantzCEOSell8,507$24.31$206,805.17View SEC Filing  
5/5/2016Roger PomerantzCEOSell59,325$26.13$1,550,162.25View SEC Filing  
5/3/2016Roger PomerantzCEOSell67,367$28.70$1,933,432.90View SEC Filing  
4/25/2016John G AuninsEVPSell18,640$31.94$595,361.60View SEC Filing  
4/7/2016David N CookEVPSell8,000$31.00$248,000.00View SEC Filing  
4/7/2016Roger PomerantzCEOSell9,212$30.00$276,360.00View SEC Filing  
4/4/2016David N CookEVPSell61,000$26.16$1,595,760.00View SEC Filing  
4/4/2016Eric D ShaffCFOSell6,568$28.85$189,486.80View SEC Filing  
4/4/2016Roger PomerantzCEOSell135,788$27.20$3,693,433.60View SEC Filing  
3/31/2016Eric D ShaffCFOSell7,663$26.30$201,536.90View SEC Filing  
3/28/2016Eric D ShaffCFOSell5,473$24.07$131,735.11View SEC Filing  
3/28/2016John G AuninsEVPSell9,390$23.89$224,327.10View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Seres Therapeutics (NASDAQ:MCRB)
DateHeadline
News IconTime To Put On The Watch List? - Intrexon (NYSE:XON), Seres Therapeutics (NASDAQ:MCRB) - The Voice Registrar (NASDAQ:MCRB)
voiceregistrar.com - September 25 at 5:26 PM
finance.yahoo.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Regarding Possible Violations of Federal Securities Laws by Certain Officers and Directors of Seres Therapeutics, Inc. - MCRB (NASDAQ:MCRB)
finance.yahoo.com - September 21 at 5:47 PM
wsj.com logoMicrobiome Companies Attract Big Investments (NASDAQ:MCRB)
www.wsj.com - September 21 at 10:11 AM
News IconSeres Therapeutics Inc (MCRB) Receives New Coverage from Analysts at Cowen and Company - DailyQuint (NASDAQ:MCRB)
dailyquint.com - September 20 at 11:14 AM
News IconSeres Therapeutics Inc (MCRB) Stock Price Down 7.7% After Insider ... - DailyQuint (NASDAQ:MCRB)
dailyquint.com - September 19 at 10:37 AM
News IconStock Down Over the Last Quarter: Seres Therapeutics, Inc ... - Post News (NASDAQ:MCRB)
www.kentuckypostnews.com - September 18 at 10:28 AM
News IconShares Higher in Current Session: Seres Therapeutics, Inc. (NASDAQ:MCRB) - Post News (NASDAQ:MCRB)
www.kentuckypostnews.com - September 12 at 5:52 PM
News IconLooking Ahead for Seres Therapeutics Inc (NASDAQ:MCRB); Are These Shares Ready to Go Higher? - Frisco Fastball (NASDAQ:MCRB)
friscofastball.com - September 12 at 5:52 PM
fool.com logo3 Stocks to Avoid in the Biotechnology Sector (NASDAQ:MCRB)
www.fool.com - September 11 at 10:14 AM
News IconPlacing Seres Therapeutics Inc (NASDAQ:MCRB) Shares Under the Microscope - Post News (NASDAQ:MCRB)
www.kentuckypostnews.com - September 8 at 9:56 AM
News IconInvestor News: Seres Therapeutics Inc (NASDAQ:MCRB) faces Investigation over potential Violations of Securities Laws (NASDAQ:MCRB)
www.groundreport.com - September 3 at 5:30 PM
News IconInvestor News: Seres Therapeutics Inc (NASDAQ:MCRB) faces Investigation over potential Violations of Securities Laws - GroundReport (NASDAQ:MCRB)
www.groundreport.com - September 2 at 3:17 PM
News IconIt's Earnings Time: What to Do with Seres Therapeutics, Inc. (NASDAQ:MCRB) Stock - The Voice Registrar (NASDAQ:MCRB)
voiceregistrar.com - September 1 at 5:56 PM
finance.yahoo.com logoSERES THERAPEUTICS, INC. Financials (NASDAQ:MCRB)
finance.yahoo.com - August 20 at 5:52 PM
News IconIntraday Active Biotech Stocks News: Sequenom (NASDAQ:SQNM), Seres Therapeutics (NASDAQ:MCRB) - The Voice Registrar (NASDAQ:MCRB)
voiceregistrar.com - August 20 at 10:13 AM
4-traders.com logoSeres Therapeutics Inc (NASDAQ:MCRB) Under Investigation for Investors over Potential Violations of Securities Laws (NASDAQ:MCRB)
www.4-traders.com - August 17 at 6:18 PM
nasdaq.com logoSeres Therapeutics Inc. (MCRB) Is Climbing On Q2 Results (NASDAQ:MCRB)
www.nasdaq.com - August 13 at 9:01 AM
schaeffersresearch.com logoSeres Therapeutics Inc (MCRB) Sizzles on 'Overdone' Selloff Talk (NASDAQ:MCRB)
www.schaeffersresearch.com - August 13 at 9:01 AM
schaeffersresearch.com logoSeres Therapeutics Inc (MCRB) Sizzles on 'Overdone' Selloff Talk - Schaeffers Research (blog) (NASDAQ:MCRB)
www.schaeffersresearch.com - August 12 at 6:11 PM
fool.com logoWhy Seres Therapeutics Inc. Shares Are Jumping Today (NASDAQ:MCRB)
www.fool.com - August 12 at 5:01 PM
biz.yahoo.com logoSERES THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:MCRB)
biz.yahoo.com - August 11 at 6:27 PM
cnbc.com logoSeres Therapeutics reports 2Q loss (NASDAQ:MCRB)
www.cnbc.com - August 11 at 9:16 AM
publicnow.com logoSeres Therapeutics Reports Second Quarter Financial Results and Provides Operational Progress Update (NASDAQ:MCRB)
www.publicnow.com - August 11 at 9:16 AM
biz.yahoo.com logoSeres Therapeutics Inc Earnings Call scheduled for 8:30 am ET today (NASDAQ:MCRB)
biz.yahoo.com - August 11 at 9:16 AM
finance.yahoo.com logoINVESTOR ALERT: Investigation of Seres Therapeutics, Inc. Announced by Law Offices of Howard G. Smith (NASDAQ:MCRB)
finance.yahoo.com - August 5 at 6:16 PM
finance.yahoo.com logoSHAREHOLDER NOTICE: Khang & Khang LLP Announces an Investigation of Seres Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm (NASDAQ:MCRB)
finance.yahoo.com - August 5 at 6:16 PM
publicnow.com logoSeres Therapeutics to Host Second Quarter 2016 Financial Results and Operational Progress Conference Call and Webcast on August 11, 2016 (NASDAQ:MCRB)
www.publicnow.com - August 5 at 9:06 AM
fortune.com logoAnalyst Ratings Worth Watching: Sarepta Therapeutics Inc ... - Review Fortune (NASDAQ:MCRB)
reviewfortune.com - August 4 at 9:15 AM
News IconNews Buzz in Analytic Views- RLJ Lodging Trust (RLJ), Seres Therapeutics (MCRB), Manhattan Associates (MANH) - Seneca Globe (NASDAQ:MCRB)
www.senecaglobe.com - August 4 at 9:15 AM
wsj.com logo[$$] Evelo Biosciences, Mayo Clinic to Study Microbiome Cancer Therapy (NASDAQ:MCRB)
www.wsj.com - August 4 at 9:15 AM
News IconSeres Therapeutics Inc (MCRB) is Downgraded by BofA/Merrill to Neutral (NASDAQ:MCRB)
bolsafinanzas.com - August 2 at 10:55 AM
News IconSeres Therapeutics, Inc. (NASDAQ:MCRB) Fails To Meet SER-109 Phase 2 ECOSPOR Clinical Trial Primary Endpoint (NASDAQ:MCRB)
wallstreetpr.com - August 2 at 10:55 AM
finance.yahoo.com logoINVESTOR NOTICE: Goldberg Law PC Announces an Investigation of Claims against Seres Therapeutics, Inc. … (NASDAQ:MCRB)
finance.yahoo.com - August 1 at 5:55 PM
businesswire.com logoINVESTOR ALERT: Hagens Berman Alerts Investors in Seres Therapeutics, Inc ... (NASDAQ:MCRB)
www.businesswire.com - August 1 at 5:55 PM
schaeffersresearch.com logoAnalyst Update: ADMA Biologics Inc, Seres Therapeutics Inc, and Heron Therapeutics Inc (NASDAQ:MCRB)
www.schaeffersresearch.com - August 1 at 5:55 PM
marketexclusive.com logoWhat’s Next For Seres Therapeutics Inc (NASDAQ:MCRB)? (NASDAQ:MCRB)
marketexclusive.com - August 1 at 5:54 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Claims against Seres Therapeutics, Inc. and Advises Investors with Losses to Contact the Firm (NASDAQ:MCRB)
finance.yahoo.com - August 1 at 5:54 PM
bloomberg.com logoBreakthrough Drugs Don't Always Break Through (NASDAQ:MCRB)
www.bloomberg.com - August 1 at 5:54 PM
insidermonkey.com logoWhat’s Next For Seres Therapeutics Inc (MCRB)? (NASDAQ:MCRB)
www.insidermonkey.com - August 1 at 5:54 PM
capitalcube.com logoSeres Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : MCRB-US : August 1, 2016 (NASDAQ:MCRB)
www.capitalcube.com - August 1 at 5:54 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Regarding Possible Violations of Federal Securities Laws by Certain Officers and Directors of Seres Therapeutics, Inc. (NASDAQ:MCRB)
finance.yahoo.com - August 1 at 5:54 PM
finance.yahoo.com logoINVESTOR NOTICE: Goldberg Law PC Announces an Investigation of Claims against Seres Therapeutics, Inc. and Advises Investors with Losses to Contact the Firm (NASDAQ:MCRB)
finance.yahoo.com - August 1 at 5:54 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Seres Therapeutics, Inc. (MCRB) (NASDAQ:MCRB)
finance.yahoo.com - August 1 at 5:54 PM
finance.yahoo.com logoIMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of Seres Therapeutics, Inc. and Advises Investors with Losses to Contact the Firm (NASDAQ:MCRB)
finance.yahoo.com - August 1 at 5:54 PM
News IconExxon Mobil Corporation (NYSE:XOM) & Seres Therapeutics (NASDAQ:MCRB) Are Stocks to Keep Your Eyes on - Money News (press release) (NASDAQ:MCRB)
www.newsismoney.com - August 1 at 10:49 AM
businesswire.com logoINVESTOR ALERT: Hagens Berman Alerts Investors in Seres Therapeutics, Inc. (NASDAQ: MCRB) to Investigation into ... - Business Wire (press release) (NASDAQ:MCRB)
www.businesswire.com - August 1 at 10:49 AM
finance.yahoo.com logoINVESTOR ALERT: Hagens Berman Alerts Investors in Seres Therapeutics, Inc. (NASDAQ: MCRB) to Investigation into Possible Securities Law Violations (NASDAQ:MCRB)
finance.yahoo.com - August 1 at 9:30 AM
News IconSeres Therapeutics stock plunges after disappointing clinical findings (NASDAQ:MCRB)
lovingfutbol.com - July 31 at 5:43 PM
breakingfinancenews.com logoH.C. Wainwright disclosed (NASDAQ:MCRB) Seres Therapeutics Inc, bumping its stock price target to $50 today (NASDAQ:MCRB)
breakingfinancenews.com - July 31 at 5:43 PM
247wallst.com logoWhy Seres Therapeutics Is Crushing Shareholders (NASDAQ:MCRB)
247wallst.com - July 30 at 5:35 PM

Social

Seres Therapeutics (NASDAQ:MCRB) Chart for Monday, September, 26, 2016


Last Updated on 9/26/2016 by MarketBeat.com Staff